Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and

Ruoxing Wang1, Jundi Wang, Amber M Paul

  • 1Department of Biological Sciences, University of Southern Mississippi, Hattiesburg, Mississippi 39406, USA.

Insights

Embryonic stem cells (ESCs) are susceptible to viral infections but cannot produce type I interferons (IFNα/β). This deficiency in innate immunity hinders their use in regenerative medicine.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Virology

Background:

  • Embryonic stem cells (ESCs) hold great promise for regenerative medicine due to their self-renewal and differentiation potential.
  • The innate immune responses of ESCs and their derivatives remain largely uncharacterized.
  • Understanding ESC immunity is crucial for their safe and effective therapeutic applications.

Purpose of the Study:

  • To investigate the innate immune responses of mouse embryonic stem cells (mESCs) to viral infections.
  • To determine the capacity of mESCs to express type I interferons (IFNα/β) upon viral challenge.
  • To elucidate the mechanisms underlying potential immune deficiencies in mESCs.

Main Methods:

  • Exposure of mESCs to live viruses (La Crosse, West Nile, Sendai) and polyinosinic:polycytidylic acid (polyIC).
  • Quantification of type I interferon (IFNα/β) expression.
  • Assessment of dsRNA-activated protein kinase (PKR) activation and cell proliferation.
  • Analysis of viral RNA receptor expression (TLR3, MDA5, RIG-I).

Main Results:

  • mESCs are susceptible to viral infection but fail to express type I interferons (IFNα/β), unlike fibroblasts.
  • PolyIC treatment, a viral dsRNA analog, induces dsRNA-activated protein kinase (PKR) in mESCs, inhibiting proliferation.
  • Key viral RNA receptors, including TLR3 and MDA5, are expressed at low levels in mESCs, and RIG-I may be inactive.

Conclusions:

  • mESCs possess functional cytosolic dsRNA-activated protein kinase (PKR) but exhibit deficient mechanisms for type I interferon (IFNα/β) expression.
  • Low expression or activity of viral RNA sensors contributes to the impaired innate immune response in mESCs.
  • These innate immune deficiencies in ESCs require consideration for their application in regenerative medicine.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...